This phenotypic plasticity is a feature of RB1 null SCLC, and the emergence of neuroendocrine low, YAP1 expressing cells has been associated with chemoresistance, activation of Notch signaling, and expression of mesenchymal and inflammation-associated genes (10, 13, 42). This evidence concerns the gene YAP1 and small cell lung carcinoma.